AstraZeneca Objections Torpedo $8 Billion Sobi Acquisition
After Sobi agreed to be acquired by Advent International and GIC Special Investments, the deal has fallen through after AstraZeneca withheld its 8% stake from the buyout offer.
The Home of the Life Sciences Industry
Explore Latest News
Bayer Looks to Prostate Cancer Drug for Next Blockbuster
Bayer has high hopes of driving its prostate cancer drug into blockbuster status, meaning over $1 billion in annual sales. This week's ARASENS trial results should help pave the road.
- Embryo-Like Model Could Advance Research in Early Human Development
- In Head-to-Head Comparison, Moderna Bests Pfizer by a Nose
- "Fourth Wave" Driven Primarily by Delta and New Omicron Data
- Mix-and-Match Vaccine Platform May Boost Immune Response & Duration
- Research Roundup: A Potential Cause of Alzheimer’s Disease and More
Get personalized job alerts
Create a job alert and receive custom job recommendations straight to your inbox.
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.